Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity
- 16 April 2009
- journal article
- Published by Wiley in Cancer Science
- Vol. 100 (5), 859-865
- https://doi.org/10.1111/j.1349-7006.2009.01115.x
Abstract
The functions of platelets and fibrinogen in protecting tumor cells from natural killer cytotoxicity have been discussed for more than 20 years. However, their exact roles and relationships in the process are still not clear. In this study, we show that tumor cells prefer to adhere to fibrinogen than to platelets, and fibrinogen can enhance the adhesion of tumor cells to platelets. Beta3 integrin plays an important role in the adhesion of B16F10 to platelets enhanced by fibrinogen. In the presence of thrombin, fibrinogen forms dense fibrin(ogen) layers around tumor cells. Tumor cells can induce platelets to aggregate and form thrombin. Platelets, as well as thrombin, can help fibrinogen protect tumor cells from lethal contact with natural killer cells and natural killer cytotoxicity. Hirudin, a specific inhibitor of thrombin, can reverse the effect of platelets on fibrinogen in blocking natural killer cytotoxicity. Our results suggest that fibrinogen helps platelets to adhere to tumor cells, and platelets in turn promote more fibrinogen to aggregate around tumor cells by forming thrombin. They facilitate each other in protecting tumor cells from natural killer cytotoxicity.This publication has 31 references indexed in Scilit:
- Experimental metastasis and primary tumor growth in mice with hemophilia AJournal of Thrombosis and Haemostasis, 2006
- Increased metastatic potential of tumor cells in von Willebrand factor‐deficient miceJournal of Thrombosis and Haemostasis, 2005
- Chemically modified heparin inhibits the in vitro adhesion of nonsmall cell lung cancer cells to P-selectinZeitschrift für Krebsforschung und Klinische Onkologie, 2005
- A platelet cloak for tumor cellsBlood, 2005
- Modified Heparin Inhibits P-selectin-mediated Cell Adhesion of Human Colon Carcinoma Cells to Immobilized Platelets under Dynamic Flow ConditionsJournal of Biological Chemistry, 2004
- Calcein-Acetyoxymethyl Cytotoxicity Assay: Standardization of a Method Allowing Additional Analyses on Recovered Effector Cells and SupernatantsClinical and Diagnostic Laboratory Immunology, 2001
- Studies on tumor-cell-induced platelet aggregation in human lung cancer cell linesZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- Inhibition by Fibrin Coagulation of Lung Cancer Cell Destruction by Human Interleukin-2-activated Killer CellsJapanese Journal of Cancer Research, 1992
- Use of PGE1 for preparation of platelet concentratesTransfusion, 1986
- The role of natural killer cells in the control of tumor growth and metastasisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1985